SlideShare a Scribd company logo
1 of 56
Visual Inspection of the cervix
Aboubakr Elnashar
Benha university Hospital
Aboubakr Elnashar
CIN
(%)
No
StudyUniversityYearAuthor
1.074458HospitalCairo1987Hammad et al
3.15453CommunitySuez canal2007Abd El All et al
3.125522HospitalAin Shams2004-
2010
Shalakany
(2012)
7.73600HospitalMinia2014Sanad et al
Prevalence of CIN in Egypt
(Elnashar, 2014)
invasive cx ca in Egypt:
0.04%
(AbdelAll et al, 2007)
Aboubakr Elnashar
Cervical cancer is a preventable disease
1. Characteristic natural course with a slow progression
through a premalignant stage.
2. Premalignant stage can be detected by noninvasive
means
(Pap smear, HPV DNA & VIA).
3. An effective treatment for the premalignant lesions
Aboubakr Elnashar
Screening in developing countries
Difference between developing & developed
countries
I. Higher incidence: 80%
II. Higher mortality: 90%
III. Different risk factors
IV. Poor financial, human & technical resources
V. Inadequate follow up
Screening as used in the developed world is
inappropriate in developing countries
Aboubakr Elnashar
Pap smear: limitations
1. Requires:
microscopes,
laboratory,
trained technicians,
pathologists,
transport of specimens,
reporting, and
supplies.
2. Immediate results are not possible: time consuming
3. Only 50% of abnormal findings (CIN and cancers)
are detected—relies on periodic re-scanning.
Sensitivity 60-70%
Aboubakr Elnashar
4. Lesions may be missed if:
Not exfoliating.
There is a barrier to exfoliation.
Cells are not sampled properly from SCJ and TZ
Abnormal cells are not transferred to the slide.
Slide cannot be read effectively {obscured by blood or
pus}.
The technician misses the precancerous cells.
Aboubakr Elnashar
 In developing countries:
Not appropriate or adequate
Not practical as a nationall screening
method:
 In developed countries:
ongoing supervision
refresher training
continued supplies
Aboubakr Elnashar
Comparison of Screening Methods
1. Sensitivity and specificity
Method Sensitivity (%) Specificity (%)
Cytology 45-85 80-98
VIA 60-90 66-96
HPV DNA 65-95 70-96
NEJM Nov17,2005
Aboubakr Elnashar
2. Screening Costs
Aboubakr Elnashar
Visual Inspection Techniques
1. Unaided Visual Inspection
2. Visual inspection with acetic acid (VIA)
3. Visual inspection with acetic acid and
magnification (VIAM)
4. Visual inspection with Lugol’s Iodine (VILI)
Aboubakr Elnashar
1. Unaided Visual Inspection
Aboubakr Elnashar
Normal Smooth, pink
Clear mucoid secretion
Central hole-'external os‘: Nulliparours-round
Multiparous-slit or criciate
Cervix in postmenopausal women is atrophic
Abnormal
Clinical interpretation:
Can be;
Infection
Ectopy (erythroplasia)
Benign tumour
Hypertrophy
Redness or congestion
Irregular surface
Distortion
Simple erosions (do not bleed on touch)
Cervical polyps (with smooth surface)
Abnormal discharge: foul smelling, dirty/greenish, cheesy white,
blood stained
Nabothian follicles
Prolapsed uterus
Suspicious of
Malignancy
Erosion that bleeds on touch or friable
Growth, with an irregular surface or friable
Aboubakr Elnashar
Normal cervix No medical intervention required. Call for
re-screening, if 35 years or above,
according to established policy.
Aboubakr Elnashar
Abnormal
cervix
Take swab for culture and send to laboratory (if
facilities available). Refer the patient
Aboubakr Elnashar
Suspicious of Malignancy
Aboubakr Elnashar
Good for Clinical Down staging
Misses Precancerous lesions
Dx at stage III & IV: ↓from 85% to 55%
Dx at stage I & II: ↑ from 15% to 45%
60% of early disease could be identified
11% were false positive
Only 15 of pre-cancerous lesions could be detected
(Singh et al 1992)
Aboubakr Elnashar
2. Visual inspection with acetic acid
(VIA)
Aboubakr Elnashar
Pathophysiological basis of VIA
 Application of 5% acetic:
1. Coagulates the proteins of the nucleus & cytoplasm
:makes the protein opaque & white.
2. Dehydrates the cells: cytoplasmic volume is
reduced & the reflection is increased.
 Duration:
Variable
Appears: after 20 sec &
Disappears: after 2 min.
Aboubakr Elnashar
Effects of a.a.:
1.on the mucous: It coagulates mucous which can
then easily removed (mucolytic).
2.on the mature glycogen-producing epithelium:
no effect
{a.a. does not penetrate below the outer one-third of
the epithelium. The cells have very small nuclei & a
large amount of glycogen (not protein)}
3.on the col. epi.:
swell & slightly opaque
particularly if the beginning signs of metaplasia are
present: makes its recognition easier.
Aboubakr Elnashar
4.on the immature metaplastic epi.:
gray & filmy.
{very thin & have large nuclei}:
5.on dysplastic cells:
white and opaue
{contain large nuclei & large amounts of chromatin
(protein)}:
6.on gland openings of the TZ.:
better outlined.
Aboubakr Elnashar
 When to perform?
Anytime during the menstrual cycle
Not during menstruation
Not using intravaginal medication
During pregnancy, at a postpartum examination
Intended for ages 20 to 50
Aboubakr Elnashar
 Prior to application of acetic acid
1. Inspect the external genitalia:
papules, vesicles, ulcerations, condylomata,
discharge, redness, swelling, excoriation.
2. Inspect the cervix: unaided
 Normal
 Abnormal:
 Suspicious
3. Use a dry cotton swab to wipe away any discharge,
blood, or mucus from the cervix.
Aboubakr Elnashar
Procedure
1. Wash the cervix with a 3%–5% acetic acid
solution.
2. Carefully inspect the cervix, especially the TZ,
with the naked eye.
Aboubakr Elnashar
Categories
Category Clinical Findings
Negative No acetowhite lesions or
faint acetowhite lesions;
polyp,
cervicitis, inflammation,
Nabothian cysts.
Positive Sharp, distinct, well-defined,
dense (opaque/dull or oyster white) acetowhite with
or without raised margins touching SCJ;
leukoplakia and
warts.
Suspicious
for cancer
ulcerative, cauliflower-like growth or
ulcer; oozing and/or bleeding on touch.
Aboubakr Elnashar
Reporting of lesions
1. VIA negative
 No significant acetowhite lesions.
 The most challenging category in VIA
 Acetowhite:
1. Nabothian cysts and polyps
2. Faint line at SCJ
3. Away from SCJ
4. Streak like
5. Dotlike areas on the columnar epithelium
6. Diffuse with columnar epithelium staining
Aboubakr Elnashar
Aboubakr Elnashar
 Negative:
Acetowhite area far from SCJ and not touching it is
insignificant.
Aboubakr Elnashar
VIA negative.
The mild acetowhite staining in a linear pattern at the
lower edge of SCJ and around the two glandular
crypt openings is the typical appearance of immature
metaplasia
Aboubakr Elnashar
VIA negative.
The button-like, acetowhite area with ill-defined
margins is due to a Nabothian cyst.
Other ill-defined acetowhite areas are due to
squamous metaplasia. Aboubakr Elnashar
Nabothian cysts appear as
spot or button-like areas
after the application of a a.
There is dot-like
acetowhitening in the
columnar epithelium in
the anterior lip.
The SCJ is fully visible.
Negative
Aboubakr Elnashar
Negative:
The cervix is unhealthy, inflamed with ulceration,
necrosis, bleeding and inflammatory exudate.
ill-defined, diffuse, pinkish-white acetowhitening with
indefinite margins blending with the rest of
epithelium (arrows). Aboubakr Elnashar
2. VIA-Positive
 Acetowhite areas:
Sharp, distinct, well-defined,
dense (opaque/dull or oyster white),
with or without raised margins
close SCJ
 identify:
1. Extension
2. Intensity of whiteness
3. Borders and demarcations
4. Size
5. Location
Aboubakr Elnashar
Leukoplakia (hyperkeratosis)
well demarcated white area
(before the application of aa),
due to keratosis, visible to the
naked eye. Usually leukoplakia is idiopathic, but it
may also be caused by chronic foreign body irritation, HPV
infection, or squamous neoplasia.
Condylomata found on the
cervix, associated with HPV
types 6 and 11. Condylomata
are usually obvious to the
naked eye (before aa ).
Aboubakr Elnashar
 Positive
Acetowhite area adjacent to SCJ is significant.
Aboubakr Elnashar
VIA-positive
well-defined, opaque
acetowhite area, with regular
margins, in the anterior lip,
adjacent to SCJ, which is
fully visible.
satellite lesions in the lower lip.
well-defined, opaque acetowhite
area, with regular margins, in
the anterior lip, adjacent to
SCJ, which is fully visible.
ill-defined white area in the lower
lip. The lesion is extending into
cervical canal.Aboubakr Elnashar
3. Suspicious for cancer
 Dull, opaque, dense acetowhite area,
with raised and rolled-out margins,
irregular surface and bleeding on
touch in the posterior lip.
The lesion is extending into the cervical
canal.
The bleeding obliterates acetowhitening.
 proliferative growth
with dense
acetowhitening and
bleeding
Aboubakr Elnashar
VIA Performance:
Sensitivity Specificity
Minimum 65% 64%
Maximum 96% 98%
Median 84% 82%
Source: Adapted from Gaffikin, 2003
Sensitivity Specificity
Minimum 37% 86%
Maximum 84% 100%
Median 51% 89%
Pap test performance:
Aboubakr Elnashar
Strengths of VIA:
 Simple, easy-to-learn, minimally dependent upon
infrastructure.
 Low start-up and sustaining costs. Requires only
acetic acid, a speculum, and a light source (flashlight).
 Can be performed by nurses and midwives.
 Results are available immediately.
 Requires only one visit.
 Accuracy is comparable to Pap smear.
 Can be followed by VILI.
Aboubakr Elnashar
Limitations:
 False-positives may overload the referral system:
unnecessary tt of women who are free of
precancerous lesions in a single-visit approach.
 Standard training and quality assurance measures
are required
 Less accurate among post-menopausal women.
 Rater dependent.
Aboubakr Elnashar
Management:
 VIA: Negative:
 follow-up after 3-5 years acc to the decided policy.
 VIA test: positive
 Offer to treat immediately. or
 Refer for colposcopy and biopsy and then offer tt if a
precancerous lesion is confirmed.
 VIA : suspicious for cancer:
Refer for colposcopy and biopsy and further
management
Aboubakr Elnashar
Visual Inspection with Acetic Acid
Using Magnification (VIAM)
Aboubakr Elnashar
Visual Inspection with Acetic Acid Using
Magnification (VIAM)
 visualization of cervix after application of aa using low
power magnification (2.5x to 4x)
Magnascope (4X)
Aboubakr Elnashar
4. Visual inspection with Lugol’s iodine (VILI)
Aboubakr Elnashar
Pathophysiological basis of VILI
Glycogen rich tissues:
mahogany brown or
black
Glycogen rich:
Squamous epithelium
Squamous metaplasia
(mature)
Glycogen poor tissues do
not take up iodine:
mustard-yellow or
saffron-color.
Glycogen poor:
Columnar epithelium
CIN
invasive cancer
Laukoplakia
(hyperkeratosis)
Condylomata
Lugol’s iodine is glycophillic
Aboubakr Elnashar
Procedure:
 Vaginal speculum exam
 Apply Lugol’s iodine solution to the cervix.
 Viewing the cervix with the naked eye to identify color
changes on the cervix.
 The 5% solution consists of 5% (wt/v) iodine and 10% (wt/v) potassium iodide(KI) mixed in distilled water and has a total iodine content of
126.5 mg/mL. Potassium iodide renders the elementary iodine soluble in water through the formation of the triiodide ion.
 It is not to be confused with tincture of iodine solutions, which consist of elemental iodine, and iodide salts dissolved in water and alcohol. Lugol's
solution contains no alcohol.
 Schiller iodine composition is same as lugol s iodine, latter been more concentrated
Aboubakr Elnashar
Procedure involving VIA and VILI
1. Soak a clean swab in 5% aa and apply to the
cervix liberally.
2. Wait 1 minute.
3. Focus on TZ.
4. Note any acetowhite lesions: location, extension,
intensity of whiteness, borders.
5. Soak a clean swab in Lugol’s iodine solution and
apply to cervix liberally
6. Note the uptake in the areas of concern noted after
acetic acid.
Aboubakr Elnashar
Categories for VILI test results:
Category Clinical Findings
Negative Squamous epithelium turns brown
columnar epithelium does not change
color; or
irregular, partial or non-iodine uptake
areas.
Positive Well-defined, bright yellow iodine non-
uptake areas touching SCJ or close to the
os if SCJ is not seen.
Suspicious
for cancer
ulcerative, cauliflower- like growth or
ulcer; oozing and/or bleeding on touch.
Aboubakr Elnashar
Reporting of lesions
VILI: test-negative
 The squamous epithelium turns
brown
 columnar epithelium does not
change color.
 scattered and irregular, partial
or non-iodine uptake areas
associated with immature
squamous metaplasia or
inflammation.
Aboubakr Elnashar
 VILI: test-positive
 Well-defined, bright yellow
iodine non-uptake areas
touching the SCJ
Aboubakr Elnashar
VILI: Suspicious for cancer
 Clinically visible
ulcerative, cauliflower-
like growth or ulcer;
oozing and/or bleeding
on touch.
Aboubakr Elnashar
Test performance:
(Sankaranarayanan et al., 2008).
SpecificitySensitivity
85.576.8VIA
85.491.7VILI
Aboubakr Elnashar
 Strengths of VILI:
 Simple, easy-to-learn that is minimally dependent
upon infrastructure.
 Low start-up and sustaining costs. Requires only
Lugol’s iodine in addition to the equipment for VIA.
 Can be performed by nurses and midwives.
 Test results are available immediately: Decreased
loss to follow-up.
 High sensitivity results in a low proportion of
false negatives.
 VILI appears to offer improved accuracy and
reproducibility over use of VIA alone.
Aboubakr Elnashar
Limitations of VILI:
 Moderate specificity may result in over-referral and
over-treatment in a single-visit approach.
 Less accurate when used in post-menopausal
 standard training and quality assurance measures
are required
 Rater dependent.
 Lugol’s solution stains underwear and other objects
but is washable..
 Lugol’s iodine is more expensive than acetic acid,
but less is needed for the test.
Aboubakr Elnashar
 Management options
 VIA: Negative:
 follow-up after 3-5 years acc to the decided policy.
 VILI: positive:
 Offer to treat immediately, (without colposcopy or biopsy,
known as the “test-and-treat” or “single-visit” approach).
 Refer for colposcopy and biopsy and then offer treatment
if a precancerous lesion is confirmed.
 VILI: suspicious for cancer:
 Refer for colposcopy and biopsy and further management:
 Surgery
 Radiotherapy
 Chemotherapy
 Palliative care
Aboubakr Elnashar
Conclusions
Visual Inspection Techniques in Low resource setting
 Noninvasive, easy to perform, inexpensive
 All requirements are available locally
 Can be performed by all levels of healthcare workers,
in almost any setting
 Accuracy is comparable to Pap smear.
 Results are available immediately
 Initial treatment can be provided at the time of the
examination
Aboubakr Elnashar
Thank you
Aboubakr Elnashar

More Related Content

What's hot

Abnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi DeleAbnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi DeleKemi Dele-Ijagbulu
 
Vaginal Hysterectomy
Vaginal HysterectomyVaginal Hysterectomy
Vaginal HysterectomyVijay Balaji
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of FibroidsSujoy Dasgupta
 
Occipito posterior position
Occipito posterior positionOccipito posterior position
Occipito posterior positionPriyanka Gohil
 
Manchester repair (Fothergill’s Operation)
Manchester repair (Fothergill’s Operation)Manchester repair (Fothergill’s Operation)
Manchester repair (Fothergill’s Operation)Yapa
 
gestational trophoblastic disease GTD
gestational trophoblastic disease GTDgestational trophoblastic disease GTD
gestational trophoblastic disease GTDOsama Warda
 
Deep transverse arrest
Deep transverse arrestDeep transverse arrest
Deep transverse arrestpriya saxena
 
PUBERTY MENORRHAGIA & BLEEDING DISORDERS Made Easy Dr Sharda Jain
PUBERTY MENORRHAGIA & BLEEDING DISORDERS  Made Easy Dr Sharda Jain PUBERTY MENORRHAGIA & BLEEDING DISORDERS  Made Easy Dr Sharda Jain
PUBERTY MENORRHAGIA & BLEEDING DISORDERS Made Easy Dr Sharda Jain Lifecare Centre
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaAboubakr Elnashar
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean sectionraj kumar
 
Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseasesikramdr01
 

What's hot (20)

Abnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi DeleAbnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi Dele
 
Postmenopausal bleeding for undergraduate
Postmenopausal bleeding for undergraduatePostmenopausal bleeding for undergraduate
Postmenopausal bleeding for undergraduate
 
Vaginal Hysterectomy
Vaginal HysterectomyVaginal Hysterectomy
Vaginal Hysterectomy
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
 
Occipito posterior position
Occipito posterior positionOccipito posterior position
Occipito posterior position
 
Female sterilisation
Female sterilisationFemale sterilisation
Female sterilisation
 
Manchester repair (Fothergill’s Operation)
Manchester repair (Fothergill’s Operation)Manchester repair (Fothergill’s Operation)
Manchester repair (Fothergill’s Operation)
 
Molar pregnancy
Molar pregnancyMolar pregnancy
Molar pregnancy
 
gestational trophoblastic disease GTD
gestational trophoblastic disease GTDgestational trophoblastic disease GTD
gestational trophoblastic disease GTD
 
Deep transverse arrest
Deep transverse arrestDeep transverse arrest
Deep transverse arrest
 
Female sterlization
Female sterlizationFemale sterlization
Female sterlization
 
PUBERTY MENORRHAGIA & BLEEDING DISORDERS Made Easy Dr Sharda Jain
PUBERTY MENORRHAGIA & BLEEDING DISORDERS  Made Easy Dr Sharda Jain PUBERTY MENORRHAGIA & BLEEDING DISORDERS  Made Easy Dr Sharda Jain
PUBERTY MENORRHAGIA & BLEEDING DISORDERS Made Easy Dr Sharda Jain
 
Hepatitis B in Pregnancy
Hepatitis B in PregnancyHepatitis B in Pregnancy
Hepatitis B in Pregnancy
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasia
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean section
 
Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseases
 
Abnormal uterine bleeding
Abnormal  uterine bleedingAbnormal  uterine bleeding
Abnormal uterine bleeding
 
Bartholian cyst
Bartholian cystBartholian cyst
Bartholian cyst
 
Cervical erosion
Cervical erosionCervical erosion
Cervical erosion
 
Colposcopy
Colposcopy Colposcopy
Colposcopy
 

Viewers also liked

Screening c cervix slideshare 2015 (1)
Screening c cervix   slideshare 2015 (1)Screening c cervix   slideshare 2015 (1)
Screening c cervix slideshare 2015 (1)Mohammad Emam
 
Colposcopy
ColposcopyColposcopy
Colposcopydrsubir
 
Visual Inspection with AceticAcid of the Cervix Uteri
Visual Inspection with AceticAcid of the Cervix UteriVisual Inspection with AceticAcid of the Cervix Uteri
Visual Inspection with AceticAcid of the Cervix UteriDr Dirk Grothuesmann
 
Introduction to visual inspection
Introduction to visual inspectionIntroduction to visual inspection
Introduction to visual inspectionChris Kay
 
Multiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr ElnasharMultiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr ElnasharAboubakr Elnashar
 
Clinically Suspicious cervix
Clinically Suspicious cervix Clinically Suspicious cervix
Clinically Suspicious cervix Aboubakr Elnashar
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septLifecare Centre
 
Presentacion cervicitis aguda y crónica
Presentacion cervicitis aguda y crónicaPresentacion cervicitis aguda y crónica
Presentacion cervicitis aguda y crónicaMi rincón de Medicina
 
Benign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organsBenign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organsRuslan Migorianu
 
JEMS Aluminium Profile
JEMS Aluminium ProfileJEMS Aluminium Profile
JEMS Aluminium Profilechetan potdar
 
Summer Training presentation
Summer Training presentationSummer Training presentation
Summer Training presentationMukul kashiwal
 
Endometrialpolyps jagdish prasad ola
Endometrialpolyps jagdish prasad olaEndometrialpolyps jagdish prasad ola
Endometrialpolyps jagdish prasad olaJagdish Ola
 
Premalignant and malignant conditions of the cervix
Premalignant and malignant conditions  of the cervix  Premalignant and malignant conditions  of the cervix
Premalignant and malignant conditions of the cervix tariggally
 
Suspicious cervix in the era of via 2015 -slide share no-copy
Suspicious cervix in the era of via   2015 -slide share  no-copy Suspicious cervix in the era of via   2015 -slide share  no-copy
Suspicious cervix in the era of via 2015 -slide share no-copy Mohammad Emam
 
Cervical screening , present past crown plaza final copy
Cervical screening , present past crown plaza  final copyCervical screening , present past crown plaza  final copy
Cervical screening , present past crown plaza final copyBasalama Ali
 
Hpv and early carcinoma cervix
Hpv and early carcinoma cervixHpv and early carcinoma cervix
Hpv and early carcinoma cervixRicha Sharma
 

Viewers also liked (20)

Screening c cervix slideshare 2015 (1)
Screening c cervix   slideshare 2015 (1)Screening c cervix   slideshare 2015 (1)
Screening c cervix slideshare 2015 (1)
 
Colposcopy
ColposcopyColposcopy
Colposcopy
 
Visual Inspection with AceticAcid of the Cervix Uteri
Visual Inspection with AceticAcid of the Cervix UteriVisual Inspection with AceticAcid of the Cervix Uteri
Visual Inspection with AceticAcid of the Cervix Uteri
 
Introduction to visual inspection
Introduction to visual inspectionIntroduction to visual inspection
Introduction to visual inspection
 
Multiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr ElnasharMultiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr Elnashar
 
Clinically Suspicious cervix
Clinically Suspicious cervix Clinically Suspicious cervix
Clinically Suspicious cervix
 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
 
Cervicitis
CervicitisCervicitis
Cervicitis
 
Presentacion cervicitis aguda y crónica
Presentacion cervicitis aguda y crónicaPresentacion cervicitis aguda y crónica
Presentacion cervicitis aguda y crónica
 
Benign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organsBenign & precancerous tumors of female genitale organs
Benign & precancerous tumors of female genitale organs
 
Improving Women's Reproductive Health Through Expanding Access to Key Health ...
Improving Women's Reproductive Health Through Expanding Access to Key Health ...Improving Women's Reproductive Health Through Expanding Access to Key Health ...
Improving Women's Reproductive Health Through Expanding Access to Key Health ...
 
JEMS Aluminium Profile
JEMS Aluminium ProfileJEMS Aluminium Profile
JEMS Aluminium Profile
 
Summer Training presentation
Summer Training presentationSummer Training presentation
Summer Training presentation
 
Endometrialpolyps jagdish prasad ola
Endometrialpolyps jagdish prasad olaEndometrialpolyps jagdish prasad ola
Endometrialpolyps jagdish prasad ola
 
Via
ViaVia
Via
 
Premalignant and malignant conditions of the cervix
Premalignant and malignant conditions  of the cervix  Premalignant and malignant conditions  of the cervix
Premalignant and malignant conditions of the cervix
 
Suspicious cervix in the era of via 2015 -slide share no-copy
Suspicious cervix in the era of via   2015 -slide share  no-copy Suspicious cervix in the era of via   2015 -slide share  no-copy
Suspicious cervix in the era of via 2015 -slide share no-copy
 
Cervical screening , present past crown plaza final copy
Cervical screening , present past crown plaza  final copyCervical screening , present past crown plaza  final copy
Cervical screening , present past crown plaza final copy
 
Hpv and early carcinoma cervix
Hpv and early carcinoma cervixHpv and early carcinoma cervix
Hpv and early carcinoma cervix
 
NDT presentation
NDT presentationNDT presentation
NDT presentation
 

Similar to Visual inspection of cervix

Colposcopy7.pdf
Colposcopy7.pdfColposcopy7.pdf
Colposcopy7.pdfJOICY45
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancyAboubakr Elnashar
 
VIA practical mo-staff nurse _npcdcs_dept. of general medicine
 VIA practical mo-staff nurse _npcdcs_dept. of general medicine VIA practical mo-staff nurse _npcdcs_dept. of general medicine
VIA practical mo-staff nurse _npcdcs_dept. of general medicinedrdduttaM
 
Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...
Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...
Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...Lifecare Centre
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancyAboubakr Elnashar
 
Gynecological causes of acute abdominal pain
Gynecological causes of  acute abdominal painGynecological causes of  acute abdominal pain
Gynecological causes of acute abdominal painAboubakr Elnashar
 
Benign n pre malignant diseases of cx
Benign n pre malignant diseases of cxBenign n pre malignant diseases of cx
Benign n pre malignant diseases of cxParika Tanwar
 
cervical biopsy procedure.pptx
cervical biopsy procedure.pptxcervical biopsy procedure.pptx
cervical biopsy procedure.pptxanjalatchi
 
FINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNACFINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNACK BHATTACHARJEE
 
Carcinoma of cervix by Dr yasir nawaz
Carcinoma of cervix by Dr yasir nawazCarcinoma of cervix by Dr yasir nawaz
Carcinoma of cervix by Dr yasir nawazAyub Medical College
 
Cervical biopsy procedure
Cervical biopsy procedureCervical biopsy procedure
Cervical biopsy procedureanjalatchi
 

Similar to Visual inspection of cervix (20)

Colposcopy7.pdf
Colposcopy7.pdfColposcopy7.pdf
Colposcopy7.pdf
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancy
 
VIA practical mo-staff nurse _npcdcs_dept. of general medicine
 VIA practical mo-staff nurse _npcdcs_dept. of general medicine VIA practical mo-staff nurse _npcdcs_dept. of general medicine
VIA practical mo-staff nurse _npcdcs_dept. of general medicine
 
Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...
Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...
Colposcopy training part 1 ,DR. SHARDA JAIN Dr. Jyoti Agarwal / Dr. Jyoti Bha...
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Benign lesions of cervix
Benign lesions of cervixBenign lesions of cervix
Benign lesions of cervix
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
 
Hysteroscopy overview
Hysteroscopy overviewHysteroscopy overview
Hysteroscopy overview
 
Management of adenxal mass during pregnancy
Management of adenxal mass during pregnancyManagement of adenxal mass during pregnancy
Management of adenxal mass during pregnancy
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
 
Gynecological causes of acute abdominal pain
Gynecological causes of  acute abdominal painGynecological causes of  acute abdominal pain
Gynecological causes of acute abdominal pain
 
Benign n pre malignant diseases of cx
Benign n pre malignant diseases of cxBenign n pre malignant diseases of cx
Benign n pre malignant diseases of cx
 
cervical biopsy procedure.pptx
cervical biopsy procedure.pptxcervical biopsy procedure.pptx
cervical biopsy procedure.pptx
 
FIRST TRIMESTER BLEEDING
FIRST TRIMESTER BLEEDINGFIRST TRIMESTER BLEEDING
FIRST TRIMESTER BLEEDING
 
FINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNACFINE NEEDLE ASPIRATION CYTOLOGY / FNAC
FINE NEEDLE ASPIRATION CYTOLOGY / FNAC
 
CERVICAL CANCER.ppt
CERVICAL CANCER.pptCERVICAL CANCER.ppt
CERVICAL CANCER.ppt
 
Colposcopy
ColposcopyColposcopy
Colposcopy
 
Carcinoma of cervix by Dr yasir nawaz
Carcinoma of cervix by Dr yasir nawazCarcinoma of cervix by Dr yasir nawaz
Carcinoma of cervix by Dr yasir nawaz
 
Cervical biopsy procedure
Cervical biopsy procedureCervical biopsy procedure
Cervical biopsy procedure
 

More from Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 

Recently uploaded

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 

Recently uploaded (20)

Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 

Visual inspection of cervix

  • 1. Visual Inspection of the cervix Aboubakr Elnashar Benha university Hospital Aboubakr Elnashar
  • 2. CIN (%) No StudyUniversityYearAuthor 1.074458HospitalCairo1987Hammad et al 3.15453CommunitySuez canal2007Abd El All et al 3.125522HospitalAin Shams2004- 2010 Shalakany (2012) 7.73600HospitalMinia2014Sanad et al Prevalence of CIN in Egypt (Elnashar, 2014) invasive cx ca in Egypt: 0.04% (AbdelAll et al, 2007) Aboubakr Elnashar
  • 3. Cervical cancer is a preventable disease 1. Characteristic natural course with a slow progression through a premalignant stage. 2. Premalignant stage can be detected by noninvasive means (Pap smear, HPV DNA & VIA). 3. An effective treatment for the premalignant lesions Aboubakr Elnashar
  • 4. Screening in developing countries Difference between developing & developed countries I. Higher incidence: 80% II. Higher mortality: 90% III. Different risk factors IV. Poor financial, human & technical resources V. Inadequate follow up Screening as used in the developed world is inappropriate in developing countries Aboubakr Elnashar
  • 5. Pap smear: limitations 1. Requires: microscopes, laboratory, trained technicians, pathologists, transport of specimens, reporting, and supplies. 2. Immediate results are not possible: time consuming 3. Only 50% of abnormal findings (CIN and cancers) are detected—relies on periodic re-scanning. Sensitivity 60-70% Aboubakr Elnashar
  • 6. 4. Lesions may be missed if: Not exfoliating. There is a barrier to exfoliation. Cells are not sampled properly from SCJ and TZ Abnormal cells are not transferred to the slide. Slide cannot be read effectively {obscured by blood or pus}. The technician misses the precancerous cells. Aboubakr Elnashar
  • 7.  In developing countries: Not appropriate or adequate Not practical as a nationall screening method:  In developed countries: ongoing supervision refresher training continued supplies Aboubakr Elnashar
  • 8. Comparison of Screening Methods 1. Sensitivity and specificity Method Sensitivity (%) Specificity (%) Cytology 45-85 80-98 VIA 60-90 66-96 HPV DNA 65-95 70-96 NEJM Nov17,2005 Aboubakr Elnashar
  • 10. Visual Inspection Techniques 1. Unaided Visual Inspection 2. Visual inspection with acetic acid (VIA) 3. Visual inspection with acetic acid and magnification (VIAM) 4. Visual inspection with Lugol’s Iodine (VILI) Aboubakr Elnashar
  • 11. 1. Unaided Visual Inspection Aboubakr Elnashar
  • 12. Normal Smooth, pink Clear mucoid secretion Central hole-'external os‘: Nulliparours-round Multiparous-slit or criciate Cervix in postmenopausal women is atrophic Abnormal Clinical interpretation: Can be; Infection Ectopy (erythroplasia) Benign tumour Hypertrophy Redness or congestion Irregular surface Distortion Simple erosions (do not bleed on touch) Cervical polyps (with smooth surface) Abnormal discharge: foul smelling, dirty/greenish, cheesy white, blood stained Nabothian follicles Prolapsed uterus Suspicious of Malignancy Erosion that bleeds on touch or friable Growth, with an irregular surface or friable Aboubakr Elnashar
  • 13. Normal cervix No medical intervention required. Call for re-screening, if 35 years or above, according to established policy. Aboubakr Elnashar
  • 14. Abnormal cervix Take swab for culture and send to laboratory (if facilities available). Refer the patient Aboubakr Elnashar
  • 16. Good for Clinical Down staging Misses Precancerous lesions Dx at stage III & IV: ↓from 85% to 55% Dx at stage I & II: ↑ from 15% to 45% 60% of early disease could be identified 11% were false positive Only 15 of pre-cancerous lesions could be detected (Singh et al 1992) Aboubakr Elnashar
  • 17. 2. Visual inspection with acetic acid (VIA) Aboubakr Elnashar
  • 18. Pathophysiological basis of VIA  Application of 5% acetic: 1. Coagulates the proteins of the nucleus & cytoplasm :makes the protein opaque & white. 2. Dehydrates the cells: cytoplasmic volume is reduced & the reflection is increased.  Duration: Variable Appears: after 20 sec & Disappears: after 2 min. Aboubakr Elnashar
  • 19. Effects of a.a.: 1.on the mucous: It coagulates mucous which can then easily removed (mucolytic). 2.on the mature glycogen-producing epithelium: no effect {a.a. does not penetrate below the outer one-third of the epithelium. The cells have very small nuclei & a large amount of glycogen (not protein)} 3.on the col. epi.: swell & slightly opaque particularly if the beginning signs of metaplasia are present: makes its recognition easier. Aboubakr Elnashar
  • 20. 4.on the immature metaplastic epi.: gray & filmy. {very thin & have large nuclei}: 5.on dysplastic cells: white and opaue {contain large nuclei & large amounts of chromatin (protein)}: 6.on gland openings of the TZ.: better outlined. Aboubakr Elnashar
  • 21.  When to perform? Anytime during the menstrual cycle Not during menstruation Not using intravaginal medication During pregnancy, at a postpartum examination Intended for ages 20 to 50 Aboubakr Elnashar
  • 22.  Prior to application of acetic acid 1. Inspect the external genitalia: papules, vesicles, ulcerations, condylomata, discharge, redness, swelling, excoriation. 2. Inspect the cervix: unaided  Normal  Abnormal:  Suspicious 3. Use a dry cotton swab to wipe away any discharge, blood, or mucus from the cervix. Aboubakr Elnashar
  • 23. Procedure 1. Wash the cervix with a 3%–5% acetic acid solution. 2. Carefully inspect the cervix, especially the TZ, with the naked eye. Aboubakr Elnashar
  • 24. Categories Category Clinical Findings Negative No acetowhite lesions or faint acetowhite lesions; polyp, cervicitis, inflammation, Nabothian cysts. Positive Sharp, distinct, well-defined, dense (opaque/dull or oyster white) acetowhite with or without raised margins touching SCJ; leukoplakia and warts. Suspicious for cancer ulcerative, cauliflower-like growth or ulcer; oozing and/or bleeding on touch. Aboubakr Elnashar
  • 25. Reporting of lesions 1. VIA negative  No significant acetowhite lesions.  The most challenging category in VIA  Acetowhite: 1. Nabothian cysts and polyps 2. Faint line at SCJ 3. Away from SCJ 4. Streak like 5. Dotlike areas on the columnar epithelium 6. Diffuse with columnar epithelium staining Aboubakr Elnashar
  • 27.  Negative: Acetowhite area far from SCJ and not touching it is insignificant. Aboubakr Elnashar
  • 28. VIA negative. The mild acetowhite staining in a linear pattern at the lower edge of SCJ and around the two glandular crypt openings is the typical appearance of immature metaplasia Aboubakr Elnashar
  • 29. VIA negative. The button-like, acetowhite area with ill-defined margins is due to a Nabothian cyst. Other ill-defined acetowhite areas are due to squamous metaplasia. Aboubakr Elnashar
  • 30. Nabothian cysts appear as spot or button-like areas after the application of a a. There is dot-like acetowhitening in the columnar epithelium in the anterior lip. The SCJ is fully visible. Negative Aboubakr Elnashar
  • 31. Negative: The cervix is unhealthy, inflamed with ulceration, necrosis, bleeding and inflammatory exudate. ill-defined, diffuse, pinkish-white acetowhitening with indefinite margins blending with the rest of epithelium (arrows). Aboubakr Elnashar
  • 32. 2. VIA-Positive  Acetowhite areas: Sharp, distinct, well-defined, dense (opaque/dull or oyster white), with or without raised margins close SCJ  identify: 1. Extension 2. Intensity of whiteness 3. Borders and demarcations 4. Size 5. Location Aboubakr Elnashar
  • 33. Leukoplakia (hyperkeratosis) well demarcated white area (before the application of aa), due to keratosis, visible to the naked eye. Usually leukoplakia is idiopathic, but it may also be caused by chronic foreign body irritation, HPV infection, or squamous neoplasia. Condylomata found on the cervix, associated with HPV types 6 and 11. Condylomata are usually obvious to the naked eye (before aa ). Aboubakr Elnashar
  • 34.  Positive Acetowhite area adjacent to SCJ is significant. Aboubakr Elnashar
  • 35. VIA-positive well-defined, opaque acetowhite area, with regular margins, in the anterior lip, adjacent to SCJ, which is fully visible. satellite lesions in the lower lip. well-defined, opaque acetowhite area, with regular margins, in the anterior lip, adjacent to SCJ, which is fully visible. ill-defined white area in the lower lip. The lesion is extending into cervical canal.Aboubakr Elnashar
  • 36. 3. Suspicious for cancer  Dull, opaque, dense acetowhite area, with raised and rolled-out margins, irregular surface and bleeding on touch in the posterior lip. The lesion is extending into the cervical canal. The bleeding obliterates acetowhitening.  proliferative growth with dense acetowhitening and bleeding Aboubakr Elnashar
  • 37. VIA Performance: Sensitivity Specificity Minimum 65% 64% Maximum 96% 98% Median 84% 82% Source: Adapted from Gaffikin, 2003 Sensitivity Specificity Minimum 37% 86% Maximum 84% 100% Median 51% 89% Pap test performance: Aboubakr Elnashar
  • 38. Strengths of VIA:  Simple, easy-to-learn, minimally dependent upon infrastructure.  Low start-up and sustaining costs. Requires only acetic acid, a speculum, and a light source (flashlight).  Can be performed by nurses and midwives.  Results are available immediately.  Requires only one visit.  Accuracy is comparable to Pap smear.  Can be followed by VILI. Aboubakr Elnashar
  • 39. Limitations:  False-positives may overload the referral system: unnecessary tt of women who are free of precancerous lesions in a single-visit approach.  Standard training and quality assurance measures are required  Less accurate among post-menopausal women.  Rater dependent. Aboubakr Elnashar
  • 40. Management:  VIA: Negative:  follow-up after 3-5 years acc to the decided policy.  VIA test: positive  Offer to treat immediately. or  Refer for colposcopy and biopsy and then offer tt if a precancerous lesion is confirmed.  VIA : suspicious for cancer: Refer for colposcopy and biopsy and further management Aboubakr Elnashar
  • 41. Visual Inspection with Acetic Acid Using Magnification (VIAM) Aboubakr Elnashar
  • 42. Visual Inspection with Acetic Acid Using Magnification (VIAM)  visualization of cervix after application of aa using low power magnification (2.5x to 4x) Magnascope (4X) Aboubakr Elnashar
  • 43. 4. Visual inspection with Lugol’s iodine (VILI) Aboubakr Elnashar
  • 44. Pathophysiological basis of VILI Glycogen rich tissues: mahogany brown or black Glycogen rich: Squamous epithelium Squamous metaplasia (mature) Glycogen poor tissues do not take up iodine: mustard-yellow or saffron-color. Glycogen poor: Columnar epithelium CIN invasive cancer Laukoplakia (hyperkeratosis) Condylomata Lugol’s iodine is glycophillic Aboubakr Elnashar
  • 45. Procedure:  Vaginal speculum exam  Apply Lugol’s iodine solution to the cervix.  Viewing the cervix with the naked eye to identify color changes on the cervix.  The 5% solution consists of 5% (wt/v) iodine and 10% (wt/v) potassium iodide(KI) mixed in distilled water and has a total iodine content of 126.5 mg/mL. Potassium iodide renders the elementary iodine soluble in water through the formation of the triiodide ion.  It is not to be confused with tincture of iodine solutions, which consist of elemental iodine, and iodide salts dissolved in water and alcohol. Lugol's solution contains no alcohol.  Schiller iodine composition is same as lugol s iodine, latter been more concentrated Aboubakr Elnashar
  • 46. Procedure involving VIA and VILI 1. Soak a clean swab in 5% aa and apply to the cervix liberally. 2. Wait 1 minute. 3. Focus on TZ. 4. Note any acetowhite lesions: location, extension, intensity of whiteness, borders. 5. Soak a clean swab in Lugol’s iodine solution and apply to cervix liberally 6. Note the uptake in the areas of concern noted after acetic acid. Aboubakr Elnashar
  • 47. Categories for VILI test results: Category Clinical Findings Negative Squamous epithelium turns brown columnar epithelium does not change color; or irregular, partial or non-iodine uptake areas. Positive Well-defined, bright yellow iodine non- uptake areas touching SCJ or close to the os if SCJ is not seen. Suspicious for cancer ulcerative, cauliflower- like growth or ulcer; oozing and/or bleeding on touch. Aboubakr Elnashar
  • 48. Reporting of lesions VILI: test-negative  The squamous epithelium turns brown  columnar epithelium does not change color.  scattered and irregular, partial or non-iodine uptake areas associated with immature squamous metaplasia or inflammation. Aboubakr Elnashar
  • 49.  VILI: test-positive  Well-defined, bright yellow iodine non-uptake areas touching the SCJ Aboubakr Elnashar
  • 50. VILI: Suspicious for cancer  Clinically visible ulcerative, cauliflower- like growth or ulcer; oozing and/or bleeding on touch. Aboubakr Elnashar
  • 51. Test performance: (Sankaranarayanan et al., 2008). SpecificitySensitivity 85.576.8VIA 85.491.7VILI Aboubakr Elnashar
  • 52.  Strengths of VILI:  Simple, easy-to-learn that is minimally dependent upon infrastructure.  Low start-up and sustaining costs. Requires only Lugol’s iodine in addition to the equipment for VIA.  Can be performed by nurses and midwives.  Test results are available immediately: Decreased loss to follow-up.  High sensitivity results in a low proportion of false negatives.  VILI appears to offer improved accuracy and reproducibility over use of VIA alone. Aboubakr Elnashar
  • 53. Limitations of VILI:  Moderate specificity may result in over-referral and over-treatment in a single-visit approach.  Less accurate when used in post-menopausal  standard training and quality assurance measures are required  Rater dependent.  Lugol’s solution stains underwear and other objects but is washable..  Lugol’s iodine is more expensive than acetic acid, but less is needed for the test. Aboubakr Elnashar
  • 54.  Management options  VIA: Negative:  follow-up after 3-5 years acc to the decided policy.  VILI: positive:  Offer to treat immediately, (without colposcopy or biopsy, known as the “test-and-treat” or “single-visit” approach).  Refer for colposcopy and biopsy and then offer treatment if a precancerous lesion is confirmed.  VILI: suspicious for cancer:  Refer for colposcopy and biopsy and further management:  Surgery  Radiotherapy  Chemotherapy  Palliative care Aboubakr Elnashar
  • 55. Conclusions Visual Inspection Techniques in Low resource setting  Noninvasive, easy to perform, inexpensive  All requirements are available locally  Can be performed by all levels of healthcare workers, in almost any setting  Accuracy is comparable to Pap smear.  Results are available immediately  Initial treatment can be provided at the time of the examination Aboubakr Elnashar